In addition, the blood eosinophil phenotype in COVID-19 did not correspond either to a tissue eosinophil phenotype, such as in allergic asthma where activated airway eosinophils displayed a very low amount of surface CD125 and high amounts of CD44 [28]. This evidence concerns the gene CD44 and COVID-19.